Advanced transdermal patches designed for consistent, controlled drug delivery through the skin. Adheres gently on the skin, releasing precise dosage directly into the bloodstream for systemic treatment.
Specifications
Consistent, prolonged drug release.
Customizable absorption profiles.
Enhanced bioavailability and avoidance of first-pass metabolism.
Single or multi-layer options for API stability.
Compact packaging for portability.
Backing Membrane
Drug Matrix
Drug-In-Adhesive Matrix
Release Liner
Specifications
Our transdermal patches deliver active pharmaceutical ingredients (APIs) through a controlled-release mechanism. With advanced adhesive formulations and permeation enhancers, the patch facilitates steady absorption and consistent delivery directly into the bloodstream.
Apply the transdermal patch to a clean, dry area of skin.
The patch releases medication, delivering it steadily into the bloodstream.
Customized absorption for steady, controlled drug release.
Dissolvable films offer a convenient, discreet delivery method.
From conceptualization to full-scale production, ARx provides the solutions for therapeutic thin films and transdermal patches.
Our expertise spans oral/gastrointestinal, sublingual, buccal, topical and transdermal delivery systems, ensuring seamless support and innovation at every stage of development.
Interested in how novel drug delivery systems compare to traditional methods?
Explore their unique advantages and identify the best fit for your formulation needs.
Transdermal patches offer an innovative delivery method that enhances drug efficacy, improves patient convenience, and sets your product apart in the competitive market. They provide sustained drug release, bypass the gastrointestinal tract, avoid first-pass hepatic metabolism, and offer a noninvasive solution for conditions requiring continuous medication delivery.
Most drugs can be formulated into transdermal patches, depending on permeability, stability, and therapeutic needs. A feasibility study can determine if transdermal delivery is the right option for your API, offering potential solutions for challenging formulations.
Transdermal patches offer controlled drug release over time, typically ranging from several hours to one week. The release rate can be tailored to meet therapeutic goals, ensuring consistent drug absorption and minimizing peak-trough fluctuations that are typically observed with oral medications.
Transdermal patches provide numerous benefits compared to tablets and capsules:
Yes, transdermal patches significantly enhance patient compliance. Their ease of application, discreet design, visibility of drug therapy, and ability to provide continuous dosing make them an attractive option for patients who may struggle with frequent pill intake or injection schedules.
Transdermal patches improve drug absorption by delivering medication directly through the skin with safe and proven permeation enhancers. This method avoids gastrointestinal barriers and first-pass metabolism, resulting in more efficient therapeutic effects.
Transdermal patches utilize USP/NF compendial or GRAS (Generally Recognized As Safe) excipients, which ensure stability, skin compatibility, and effective drug delivery. Common excipients include adhesive polymers, permeation enhancers, and skin-friendly stabilizers.
Our team offers an end-to-end approach to developing transdermal patches, from initial formulation to full-scale cGMP manufacturing. To ensure market success, we provide services, including design optimization, clinical supplies production, regulatory compliance support, and stability testing.
With end-to-end, scalable capabilities in manufacturing, development, and quality management, we ensure every project stage aligns with your goals and regulatory requirements.
